Clinical trialNCT00575588CompletedPhase 3Interventional

52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period

SponsorAstraZenecaEnrollment891Type 2 Diabetes

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Burkhard Goke
University of Munich, Germany
Principal Investigator
clinicaltrials.gov ↗
Deborah Price, MSc
AstraZeneca
Study Chair
clinicaltrials.gov ↗
Peter Ohman, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

94 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Finland

Research Site
Hanko, Finland
Research Site
Helsinki, Finland
Research Site
Kuopio, Finland
Research Site
Kuusankoski, Finland
Research Site
Mikkeli, Finland
Research Site
Oulu, Finland
Research Site
Tampere, Finland

Germany

Research Site
Aschaffenburg, Germany
Research Site
Berlin, Germany
Research Site
Dortmund, Germany
Research Site
Frankfurt, Germany
Research Site
Hamburg, Germany
Research Site
Hanover, Germany
Research Site
Mainz, Germany
Research Site
Mannheim, Germany
Research Site
Mülheim, Germany
Research Site
Pirna, Germany
Research Site
Ratzeburg, Germany
Research Site
Reinfeld, Germany
Research Site
Rhaunen, Germany
Research Site
Schmiedeberg, Germany
Research Site
Tübingen, Germany
Research Site
Wahlstedt, Germany
Research Site
Weinheim, Germany

Hungary

Research Site
Balatonfüred, Hungary
Research Site
Budapest, Hungary
Research Site
Békéscsaba, Hungary
Research Site
Debrecen, Hungary
Research Site
Gyula, Hungary
Research Site
Kalocsa, Hungary
Research Site
Kaposvár, Hungary
Research Site
Kecskemét, Hungary
Research Site
Miskolc, Hungary
Research Site
Mosonmagyaróvár, Hungary
Research Site
Nyíregyháza, Hungary
Research Site
Székesfehérvár, Hungary

India

Research Site
Bangalore, Karnataka, India
Research Site
Indore, Madhya Pradesh, India
Research Site
Mumbai, Mashatra, India
Research Site
Jaipur, Rajasthan, India

54 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2007
Primary completion: 31 Aug 2009
Completion: 31 Aug 2010
Last update posted: 21 Mar 2012
Registered enrollment: 891
Registry id: NCT00575588

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.